Psoriasiform lesions appearing in three patients with rheumatoid arthritis during therapeutic administration of abatacept, a selective inhibitor of T-cell costimulation

J Eur Acad Dermatol Venereol. 2012 Feb;26(2):257-8. doi: 10.1111/j.1468-3083.2011.04042.x. Epub 2011 Mar 24.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Abatacept
  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / pharmacology
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Female
  • Humans
  • Immunoconjugates / adverse effects
  • Immunoconjugates / pharmacology
  • Immunoconjugates / therapeutic use*
  • Lymphocyte Activation / drug effects
  • Male
  • Middle Aged
  • Psoriasis / chemically induced*
  • Psoriasis / complications
  • T-Lymphocytes / drug effects*
  • T-Lymphocytes / immunology

Substances

  • Antirheumatic Agents
  • Immunoconjugates
  • Abatacept